Document:

Rash Employment Agreement

 

EMPLOYMENT AGREEMENT

This Employment Agreement (the "Agreement") is dated as of September 5, 2003 and between Advanced Bio/Chem, Inc., a Nevada corporation (the "Company"), and Steven Rash (the "Officer").

WHEREAS, the Company desires to retain the services of the Officer to act as an officer of the Company, and the Officer desires to be employed by the Company in such capacity, upon the terms and conditions set forth in this Agreement;

NOW, THEREFORE, in consideration of the premises and of the covenants and agreements herein provided, the parties hereto agree as follows:

1. EMPLOYMENT TERMS    

 

1.1 Term. The Company hereby employs the Officer, and the Officer hereby accepts employment with the Company, all in accordance with the terms and conditions hereof, for a term commencing on the date hereof and terminating on September 5, 2006. However, the Officer shall be considered to be employed by the Company beyond the Termination Date for purposes of receiving certain benefits conferred under this Agreement, as described in Section 3.1 hereof.

1.2    Position and Duties.

(a) The Company hereby employs the Officer, and the Officer agrees to serve the Company, as an officer of the Company pursuant to the terms of this Agreement. The Company has by action of its Board of Directors appointed the Officer to the position of Chief Executive Officer, however it may, in the sole and unfettered discretion of the Board of Directors, amend the Officer's title and/or duties and responsibilities, provided that the Officer remains an officer of the Company pursuant to the terms of this Agreement.

(b) The Officer shall be responsible for such duties as are commensurate with the office in which he serves and as may from time to time be assigned to the Officer by the Company's Board of Directors.

1.3    Performance of Duties.

(a) At all times prior to the Termination Date, the Officer (i) shall devote his full business time, energies, best efforts, and attention to the business of 'the Company, (ii) shall faithfully and diligently perform the duties of his employment with the Company, (iii) shall do all reasonably in his power to promote, develop, and extend the business of the Company, and (iv) shall not enter into the service of, or be employed in any capacity or for any purpose whatsoever by, any person, firm or corporation other than the Company without the prior written consent of the Board of Directors of the Company.

(b) The Officer shall perform his duties in accordance with all applicable laws, rules, or regulations that apply to the Company and/or its business, assets (real or personal), or employees.

 

2.    COMPENSATION.

2.1    Salary.

 

(a) For so long as Officer is employed by the Company, the Company agrees to pay to the Officer, and the Officer shall accept from the Company, for all of his services rendered pursuant to this Agreement, a salary of (Two Hundred and Fifty Thousand Dollars) $250,000 per annum payable semimonthly.

(b) The Company's Board of Directors, or compensation committee shall review the Officer's salary annually and merit increases thereon shall be considered and may be approved, in the sole and unlimited discretion be reviewed annually by the Company's Board of Directors, and merit increases thereon shall be considered and may be approved, in the sole and unlimited discretion of the Company's Board of Directors, depending in part on the profits and cash flow of the Company. If the Company's Board of Directors or Compensation Committee elects in its discretion to increase the salary of the Officer at any time or from time to time, the new salary rate shall, without further action by the Officer or the Company, be deemed substituted for the amount set forth above. At such time, this Agreement shall be deemed amended accordingly (notwithstanding the provisions of Paragraph 5.7 below), and, as so amended, shall remain in full force and effect.

 

2.2 Bonuses. The Company, in the sole and unfettered discretion of its Board of Directors or Compensation Committee, may from time to time award cash bonuses to the Officer based upon its measure of Officer's performance. Such bonuses may be awarded in a lump sum or may be conditioned upon the future performance or employment of Officer, in the sole and unfettered discretion of the Board of Directors of the Company.

2.3 Expenses. Upon submission of appropriate invoices or vouchers, the Company shall pay or reimburse the Officer for all reasonable expenses incurred by the Officer in the performance of his duties hereunder in furtherance of the business of the Company.

2.4 Benefits. The Company extends to the Officer the right to participate in whatever employee benefit plans (excluding any employee benefit plan covered separately in this Agreement) may be in effect from time to time, to the extent the Officer is eligible under the terms of the plans. However, no employee benefits other than those specifically conferred by the terms of this Agreement have been promised to the Officer in connection with this employment. The adoption of one or more employee benefit plans, the terms of the plans, and the Officer's participation in the

plans, if any,- are in the sole discretion of the Company and may be changed by the Company at any time and from time to time.

2.5    Stock Grant

To induce the Officer to accept the position of Chief Executive Officer, the Officer is hereby granted from the Company Eight Hundred Twenty Five Thousand (825,000) common shares of stock upon the execution of this agreement. If the Officer voluntarily resigns from the Company within 90 days from the execution of this agreement then a prorate amount of Six Hundred Thousand (600,000) common shares shall be returned to the Company. If the Officer resigns from the Company during this 90 day period as the result of gross misrepresentations made by the Company or its Officers then all common shares of stock granted are vested and all stock options granted are immediately converted into a stock grant for common shares. In light of the Company's current financial condition, prospects and ability to exist as a going concern, the shares issued to the Officer shall be based on an evaluation of par value for all legal, accounting and tax purposes. Notwithstanding the foregoing, the restricted nature of the shares received by the Officer and under current market conditions, the shares could not be reasonably liquidated at an ascertainable value greater than par. The common shares shall have demand registration rights and/or piggyback registration rights as well as anti-dilution rights.

The shares represented by this certificate are subject to, and transferable only upon compliance with, all of the terms and conditions of the Articles of Incorporation of the issuing corporation, and that Employment Agreement between Steven Rash and the issuing corporation dated as of September 5, 2003 a copy of each of which is on file at the principal office of the issuing corporation.

Stock Options. The Officer is hereby granted the right and option to purchase from the Company, for the-price and sum of $0.80 per share, Two Hundred Thousand (200,000) shares of the common stock of the Company. The Option Agreement shall contain customary terms,, including without limitation, provisions for "cashless" exercise, change of control, and price based anti-dilution and piggyback registration rights.

(a) All stock certificates issued by the Company as a result of the exercise by the Officer of the option provided by this section shall be endorsed with the following legend and any other legend required by the Company of all issued shares at the time of the issuance of stock certificates to the Officer:

The shares represented by this certificate are subject to, and transferable only upon compliance with, all of the terms and conditions of the Articles of Incorporation of the issuing corporation, and that Employment Agreement between Steven Rash and the issuing

 

corporation dated as of September 5, 2003 a copy of each of which is on file at the principal office of the issuing corporation.

 

2.6 Vacation; Sick Leave. The Company's vacation and sick leave policy will be established by the Company and may be changed by the Company at any time and from time to time. The Officer will not be entitled to receive payment for any unused sick leave either during employment or upon termination of employment.

 

2.7 Withholding. The Company may withhold from any amounts payable under this Agreement any and all federal, state, city, or other taxes or other amounts required to be withheld by any applicable law.

 

3. TERMINATION.

 

3.1  Termination Upon 30 Days Notice.

 

(a) Either party may terminate the Officer's employment under this Agreement for any reason whatsoever, either with or without cause, upon giving the other party no less than thirty (30) days prior written notice of such termination (the "Notice Date"). The effective date of a termination pursuant to this Paragraph 3.1 shall be such termination date as stated on the notice, provided that the termination date can be no earlier than the 31st day following the day the notice becomes effective pursuant to Paragraph 5.4 below (the "Termination Date").

 

(b) Until the expiration of the contract on September 5, 2006 ("Transition Period "), unless terminated for "Cause" as defined in section 3.4 or if the Officer resigns from his position or duties, the Officer will continue to be considered as an employee of the Company only for the purpose of receiving the compensation and benefits awarded in Sections 2.1, 2.2, 2.4, 2.5, and 2.8 hereof. More specifically, for the duration of Transition Period the Officer (i) shall continue to receive his salary at the rate in effect as of the Notice Date, (ii) shall continue to be considered an employee of the Company for purposes of determining eligibility to receive any contingent or deferred bonuses awarded to the Officer prior to the Termination Date, (iii) shall continue to be considered an officer of the Company for purposes of vesting in Stock Options, and (iv) shall, to the extent allowed by such plan, remain eligible to participate in any benefit plan of the Company in which the Officer participates as of the Notice Date.

(c) Notwithstanding any provision herein to the contrary, however, the Officer will not be entitled to act as, or represent himself to be, an officer or employee of the Company following the Termination Date and will not be entitled to receive or participate in any bonus, incentive, or benefit program, involving stock or otherwise, that is established following the Termination Date.

 

    3.2  Termination by Mutual Consent. The Officer and the Company may at any time terminate the employment of the Officer under this Agreement by mutual consent in writing upon the terms and conditions stated in such writing.

 

    3.3 Termination Upon Death. If the Officer dies, his employment shall immediately terminate automatically as of the date of his death. In such event, the Officer shall be treated as if he had terminated his employment with the Company under the terms of Section 3.1 above, with the date of his death serving as both the Notice Date and the Termination Date.

 

    3.4  Termination for Cause. This Agreement may be terminated for Cause by either party for the following reasons, only:

 

3.4.a.1 Commission of a criminal offense by either party in the course of performance of the Agreement shall entitle the other to effect immediate termination upon giving written notice;

3.4.a.2 If either party becomes insolvent or makes a general assignment for the benefit of creditors or if a petition in bankruptcy is filed against the defaulting party and is not discharged or disputed within five (5) working days of such filing or if the agent is adjudicated bankrupt or insolvent;

3.4.a.3 The election of one party (the "aggrieved party") to terminate this Agreement upon (1) the actual breach or actual default by the other party in the reasonable performance of the defaulting party's obligations and duties under this Agreement and (2) the failure of the defaulting party to cure the same within fifteen. (15) days (the "cure period") after receipt by the defaulting party of a good faith written notice from the aggrieved party specifying such breach or default and (3) provided that the defaulting party has not cured the default and the aggrieved party may then give written notice to defaulting party of his or its election to terminate ten (10) days after expiration of the cure period.

 

4. PROPRIETARY INFORMATION AND ITEMS

4.1 Acknowledgments. The Officer acknowledges that (a) the Officer has or will be afforded access to Proprietary Information of the Company or its affiliates; (b) public disclosure of such Proprietary Information could have an adverse effect on the Company and its affiliates; and (c) the provisions of this Section 4 are reasonable and necessary to prevent the improper use or disclosure of such Proprietary Information.

4.2 Non-Disclosure and Non-Use of Proprietary Information. During the Officer's employment by the Company and for a period of ten (10) years thereafter, the Officer covenants and agrees that the Officer (a) shall not disclose to others or use for the benefit of himself or others, any of the Company's Proprietary Information, except that the Officer may disclose such information (i) in the course of and in furtherance of the Officer's employment with the Company to the extent

necessary for the benefit of the Company, (ii) with the prior specific written consent of the Board of Directors of the Company, or (iii) to the extent required by law; and (b) shall take all measures reasonably necessary to preserve the confidentiality of all Proprietary Information of the Company known to the Officer, shall cooperate fully with the Company's or its affiliates' enforcement of measures intended to preserve the confidentiality of all Proprietary Information, and shall notify the Board of Directors immediately upon receiving any request for, or making any disclosure of, any Proprietary Information from or to any person other than an officer or employee of the Company or of one of its affiliates who has a need to know such information.

 

4.3 Proprietary Information. For . purposes of this Agreement, "Proprietary Information" means trade secrets, secret or confidential information or knowledge pertaining to, or any other nonpublic information pertaining to the business or affairs of the Company or any of its affiliates, including without limitation, medical imaging software programs (including source code and object code) and design documentation; identities, addresses, backgrounds, or other information regarding customers, potential customers, employees, contractors, or sources of referral; marketing plans or strategies; business or personnel acquisition plans; pending or contemplated projects, ventures, or proposals; financial information (including historical financial statements; financial, capital, or operating budgets, plans, or projections; historical or projected sales; and the amounts of compensation paid to employees and contractors); trade secrets, know-how, technical processes, or research projects; and notes, analysis, compilations, studies, summaries, and other material prepared by or for the Company containing or based, in whole or in part, on any information included in the foregoing, except information that is generally known in the industry (other than as a result of a disclosure by the Officer).

 

4.4 Proprietary Items. Upon termination or expiration of the Officer's employment by the Company for any reason or by either party, or upon the request of the Company during such tenure, the Officer will immediately return to the Company all Proprietary Items in the Officer's possession or subject to the Officer's control, and the Officer shall not retain any copies, abstracts, sketches, or other physical embodiment of any Proprietary Items. For purposes of this Agreement, "Proprietary Items" means all documents and tangible items (including all customer lists, memoranda, books, papers, records, notebooks, plans, models, components, devices, or computer software or code, whether embodied in a disk or in any other form) provided to the Officer by the Company, created by the Officer, or otherwise coming into the Officer's possession for use in connection with his engagement with the Company or otherwise containing Proprietary Information (whether provided or created during the term of this Agreement or prior thereto).

4.5 Ownership Rights. The Officer recognizes that, as between the Company and the Officer, all of the Proprietary Information and all of the Proprietary Items, whether or not developed by the Officer, are the exclusive property of the Company. The Officer agrees that all intellectual property of every kind, including without limitation copyright, patent, trademarks, trade secrets, and similar rights, created or developed or realized in connection with the Officer's performance of any duties or functions as an Officer of the Company (collectively, the "Intellectual Property") shall be the exclusive property of the Company and shall constitute Proprietary Information. The Officer hereby assigns unto the Company all rights, title, and interest that the Officer may have to such

Intellectual Property and each and every derivative work thereof, and agrees to execute, acknowledge, and deliver to the Company an assignment to the Company of any right, title, or interest of the Officer in any and all such Intellectual Property, in such form as may be reasonably requested by the Company.

 

4.6 Disputes or Controversies. The Officer recognizes that, should a dispute or controversy arising from or relating to this Agreement be submitted for adjudication to any court, arbitration panel, or other third party, the preservation of the secrecy of Proprietary Information may be jeopardized. The Officer agrees that he will use best efforts to ensure that all pleadings, documents, testimony, and records relating to any such adjudication will be maintained in secrecy.

 

5. NON-INTERFERENCE; COMPLIANCE WITH LAW; COOPERATION

 

5.1 Non-Interference. During the Officer's employment with the Company and for a period of five (5) years following termination or expiration of such tenure, the Officer covenants and agrees that the Officer shall not, directly or indirectly, for the benefit of the Officer or another, (a) persuade or attempt to persuade any employee, independent contractor, consultant, agent, supplier, or distributor of the Company or of any affiliate of the Company to discontinue such person's relationship with the Company or the affiliate; (b) hire away or solicit to hire away from the Company or from any of its affiliates any employee; (c) otherwise engage or seek to engage any employee or independent contractor of the Company or of any of its affiliates in a business relationship that would or might conflict with such employee's or independent contractor's obligations to the Company or affiliate; (d) interfere with the Company's or any of its affiliates' relationship with any governmental or business entity, including any payor, supplier, lender, or contractor of the Company or the affiliate; or (v) disparage the Company or any of its affiliates or any of the shareholders, directors, officers, employees, or agents of any of them.

5.2 Cooperation. During the Officer's employment with the Company and for a period of five (5) years following the termination or expiration of such tenure, the Officer agrees to cooperate with the Company and its affiliates in connection with any litigation or investigation involving the Company or any of its affiliates or any of the shareholders, directors, officers, employees, or agents of any of them and shall furnish such information and assistance as may be lawfully requested by the Company.

 

6. NON-COMPETITION

 

During the Officer's employment by the Company and for a period of two (2) years following the termination or expiration of such tenure, the Officer covenants and agrees to refrain from carrying on or engaging in a business similar to that of the Company, and from soliciting customers of the Company, within North America, so long as the Company carries on a like business therein. Each word of the foregoing provision is severable.

 

7. GENERAL PROVISIONS

7.1 Indemnification. The Company hereby agrees to indemnify and hold harmless the Officer from and against any and all losses, claims, damages, expenses and/or liabilities which may incur arising out of the normal course of business in carrying out the duties and responsibilities associated with the position of Chief Executive Officer arising from the Officer's reliance upon and approved use of information, reports and data furnished by and representations made by the Company, with respect to itself; where the Officer in turn distributes and conveys such information, reports and data to the public in the normal course of representing the Company. Such indemnification shall include, but not be limited to, expenses (including all attorney's fees), judgments, and amounts paid in settlement actually and reasonably incurred by Officer in connection with an action, suit or proceeding brought against the Company or Officer.

7.2 Injunctive Relief. The Officer acknowledges that the injury that would be suffered by the Company as a result of a breach of the provisions of this Agreement would be largely irreparable and that an award of monetary damages to the Company for such a breach would be an inadequate remedy. The Company will have the right, in addition to any other rights it may have (including the right to damages that the Company may suffer), to obtain injunctive relief to restrain any breach or threatened breach or otherwise to specifically enforce any provision of this Agreement, and the Company will not be obligated to post bond or other security in seeking such relief. The Officer agrees to request neither bond nor security in connection with any such injunction. The Officer agrees that if he breaches this Agreement, the Officer shall be liable for any attorney's fees and costs incurred by the Company in enforcing its rights under this Agreement.

 

7.3  Essential, Independent, and Surviving Covenants.

(a) The parties agree that the covenants by the Officer in Sections 4, 5, and 6 are essential elements of this Agreement, and without the Officer's agreement to comply with such covenants, the Company would not have entered into this Agreement.

(b) The Officer's covenants in Sections 4, 5 and 6 are independent covenants and the existence of any claim by the Officer against the Company under this Agreement or otherwise will not excuse the Officer's breach of any covenant in Section 4, 5, or 6.

(c) After the Officer's employment by the Company : is terminated, this Agreement will continue in full force and effect as is necessary or appropriate to enforce the covenants and agreements of the Officer in Sections 4, 5, and 6.

 

    7.4 Binding Effect; Benefits; Assignment. This Agreement shall inure to the benefit of, and shall be binding upon, the parties hereto and their respective successors, assigns, heirs, and legal representatives. Insofar as the Officer is concerned, this contract, being personal, cannot be assigned other than by will or the laws of descent and distribution.

 

    7.5 Notices. All notices and other communications which are required or permitted hereunder shall be in writing and shall be sufficient if mailed by certified mail, postage prepaid, and shall be effective three days after such mailing or upon delivery, whichever is earlier, to the

following addresses or such other address as the appropriate party may advise each other party hereto

If to the Officer: Steven Rash

 

If to the Company:

Advanced Bio/Chem, Inc. 4800 Research Forest Drive The Woodlands, TX 77381

Copy to:

Locke Liddell Sapp, LLP Attn: David Peterman

    

      7.6 Entire Agreement. This Agreement contains the entire agreement between the parties hereto and supersedes all prior agreements and understandings, oral or written, between the parties hereto with respect to the subject matter hereof.

 

7.7 No Third-Party Beneficiaries. This Agreement shall not confer any rights or remedies upon any person other than the Company, the Officer, and their respective successors and permitted assigns, other than as expressly set forth in this Agreement.

7.8 Amendments and Waivers. Except as set forth in Paragraph 2.1(b) above, this Agreement may not be modified or amended except by an instrument or instruments in writing signed by the party against whom enforcement of any such modification or amendment is sought. Either party hereto may, by an instrument in writing, waive compliance by the other party with any term or provision of this Agreement on the part of such other party hereto to be performed or complied with. The waiver by any party hereto of a breach of any term or provision of this Agreement shall not be construed as a waiver of any subsequent breach. No delay or failure by either party in exercising any right under this Agreement, and no partial or single exercise of that right, shall constitute a waiver of that or any other right.

7.9 Headings. The paragraph headings contained in this Agreement are for reference purposes only and shall not be deemed to be a part of this Agreement or to control or affect the meaning or construction of any provision of this Agreement.

7.10 Construction. The language used in this Agreement will be deemed to be the language chosen by the Company and the Officer to express their mutual intent, and no rule of strict construction shall be applied against either party.

 

     7.11 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.

 

    7.12 Severability. If any term or provision of this Agreement is held or deemed to be invalid or unenforceable, in whole or in part, by a court of competent jurisdiction, this Agreement shall be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement.

 

    7.13 Expenses and Attorney's Fees. In the event that a dispute arises under this Agreement that results in litigation or arbitration, the prevailing party, as determined by the decision of a court or forum of competent and final jurisdiction, shall be entitled to court costs and reasonable attorney's fees. A court or forum of "final" jurisdiction shall mean a court or forum from which no appeal may be taken or from whose decree, decision, judgment, or order no appeal is taken or prosecuted.

 

    7.14 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada, without regard to the conflict of laws principles thereof.

    

    7.15 Agreement Preparation. The Officer acknowledges that this Agreement has been prepared by counsel for the Company, and the Officer has not relied on any representation made by the Company's attorneys. The Officer has engaged an attorney of his choice to review this agreement on his behalf. By signing this employment agreement, officer is hereby certifying that officer (a) received a copy of this agreement for review and study before executing it; (b) read this agreement carefully before signing it; (c) had sufficient opportunity before signing the agreement to ask any questions officer had about the agreement and received satisfactory answers to all such questions; and (d) understands officer's rights and obligations under the agreement.

IN WITNESS WHEREOF, the parties hereto have duly executed this Employment Agreement as of the date first written above.

 

OFFICER:

 

/s/ Steven Rash    

Steven Rash

 

COMPANY

Advanced Bio/Chem, Inc.

By: /s/ Helen R. Park               

Helen R. Park Chairman of the BoardFiled by Automated Filing Services Inc. (604) 609-0244 - Global Innovative Systems, Inc. - Exhibit 10.3

 LETTER OF INTENT 

September 21, 2004 

	 To:  	 Tech Team Holdings Limited  
	  	 1703, Top Glory Tower  
	  	 262 Gloucester Road  
	  	 Causeway Bay, Hong Kong  
	  	 
	 RE:  	 Purchase of all of the issued and outstanding
      securities (the "Securities") in the capital of Tech Team Holdings
      Limited  

                    The
  following sets out the basic terms upon which Global Innovative Systems, Inc.
  would be prepared to purchase the Securities. The terms are not comprehensive
  and additional terms, including reasonable warranties and representations,
  will be incorporated into a formal agreement (the "Formal Agreement") to be
  negotiated. The basic terms are as follows: 

	 1.      	 Purchaser:
        Global Innovative Systems, Inc. (the "Purchaser") 

	 
	 2.      	 Target: Tech
        Team Holdings Limited (the "Target") 

	 
	 3.      	 Principal Shareholders:
        Victor Chang, Bondy Tan, Dr. Charles Cheung and any other securityholders
        of the Target (the "Vendors") 

	 
	 4.      	 Shares: The
        Purchaser agrees to purchase from the Vendors and the Vendors agree to
        sell, assign and transfer and to cause all holders of the Securities to
        sell, assign and transfer to the Purchaser, the Securities free and clear
        of all liens, charges and encumbrances. 

	 
	 5.      	 Transaction:
        The Purchaser, the Target and the Vendors will enter into a business combination
        (the "Combination") whereby the Purchaser will purchase the Securities
        (which represent all of the issued and outstanding securities in the capital
        of the Target) from the Vendors in exchange for 10,000,000 shares in the
        capital of the Purchaser after giving effect to a four (4) for one (1)
        forward split (the “Forward Split”) of the issued and outstanding
        shares of the Purchaser (the "Acquisition"). The Purchaser agrees that
        there will be no more than 6,033,096 of its shares issued and outstanding
        after the Forward Split and prior to the completion of the Acquisition.
      

	 
	 6.      	 Structure:
        In order to facilitate the Acquisition, the Purchaser, the Target and
        the Vendors agree that each will use their best efforts to formulate a
        structure for the Combination which is acceptable to each of the parties
        and which is formulated to: 

	 
	 	•	  comply with all necessary legal and regulatory
        requirements; 

 

	 	• 	minimize or eliminate any adverse tax consequences;
      and 
	 
	 	• 	be as cost effective as possible. 
	 
	 7.      	 Due Diligence Deposit: Upon execution
        of this Letter of Intent, the Vendors and/or the Target agree that they
        will deposit with Clark, Wilson (Vancouver, British Columbia) the amount
        of $25,000 (the "Due Diligence Deposit") which will be used to pay
        the existing liabilities of the Purchaser (estimated to be $19,000)
        and for the due diligence and other expenses related to the Acquisition.
        The Due Diligence Deposit shall be non-refundable but may be converted
        into a private placement in the shares of the Purchaser assuming the Acquisition
        is consummated. In all other circumstances the Due Diligence Deposit will
        become a non –refundable payment to the Purchaser. 

	 
	 8.      	 Access to Information: The parties
        hereto agree that immediately upon execution of this Letter of Intent:
      

	 
	 	• 	 the Purchaser and its respective advisors will have
        full access during normal business hours to, or the Vendors will deliver
        to the Purchaser, copies of all documents pertaining to the operations
        of the Target; and 

	 
	 	• 	 the Vendors and its respective advisors will have
        full access during normal business hours to, or the Purchaser will deliver
        to the Vendors, copies of all documents pertaining to the operations of
        the Purchaser. 

	 
	 9.      	 Return of Materials: Each of the
        parties agrees to return or destroy any materials delivered in accordance
        with Section 8 of this Letter of Intent if the Formal Agreement is not
        executed within the time provided. 

	 
	 10.      	 Condition(s) Precedent for the Purchaser:
        The obligation of the Purchaser to purchase the Securities will be subject
        to satisfaction or written waiver by the Purchaser of the following condition(s)
        (the "Conditions Precedent") within 10 days after execution and delivery
        of the Formal Agreement: 

	 
	 	• 	 review and approval of all materials in the possession
        and control of the Target and the Vendors which are germane to the decision
        to purchase the Securities; 

	 
	 	• 	 the Purchaser and its solicitors having had a reasonable
        opportunity to perform the searches and other due diligence reasonable
        or customary in a transaction of a similar nature to that contemplated
        herein and that both the solicitors and the Purchaser are satisfied with
        the results of such due diligence; 

	 
	 	• 	 the Purchaser and its accountant having had a reasonable
        opportunity to review the audited financial statements (including corporate
        tax returns, general ledger listings, adjusting entries and opening trial
        balances) of the Target, prepared in accordance with generally accepted
        accounting principles and that both the Purchaser and its accountant are
        satisfied with the content of such financial statements; 

 

	 	• 	 satisfactory arrangements being made to hire hourly
        and salaried staff necessary to operate the business of the Target including
        the Target entering into an executive management contract with Victor
        Chang and Bondy Tan; 

	 
	 	• 	 the Purchaser obtaining the consent from any parties
        from whom consent to the transfer of the Securities is required; 

	 
	 	• 	 the Purchaser obtaining confirmation that any names
        used in the business of the Target is available for use by the Purchaser
        and can be registered as a trade mark of the Purchaser; 

	 
	 	• 	 no material adverse change having occurred in connection
        with the business of the Target or the Securities; 

	 
	 	• 	 all representations and warranties of the Target
        and the Vendors being true and all covenants of the Target and the Vendors
        having been performed in all material respects as of the Closing; 

	 
	 	• 	 no legal proceedings pending or threatened to enjoin,
        restrict or prohibit the transactions contemplated in this Letter of Intent;
      

	 
	 	• 	 a satisfactory legal opinion being available from
        counsel for the Vendors; 

	 
	 	• 	 completion of satisfactory physical inspection of
        the assets of the Target; 

	 
	 	• 	 satisfactory review of title to the assets of the
        Target; 

	 
	 	• 	 approval of the Board of Directors of the Purchaser
        being obtained; 

	 
	 	• 	 approval of the Board of Directors of the Target
        and approval of all of the securityholders of the Target being obtained.
      

	 
	 	
It would be the expectation of the Purchaser that many
        of the Conditions Precedent will be narrowed or eliminated altogether
        as the Purchaser completes its due diligence and the Formal Agreement
        and schedules thereto are finalized. 

	 
	 11.      	 Conditions Precedent for the Vendors:
        The obligation of the Vendors to proceed with the Combination will be
        subject to satisfaction or written waiver by the Vendors of the following
        condition(s) (the "Vendors’ Conditions Precedent") within 10 days
        after execution and delivery of the Formal Agreement: 

	 
	 	• 	 review and approval of all materials in the possession
        and control of the Purchaser which are germane to the decision to proceed
        with the Combination; 

	 
	 	• 	 the Vendors and their solicitors having had a reasonable
        opportunity to perform the searches and other due diligence reasonable
        or customary in a transaction of a 

 

	 	 	 similar nature to that contemplated herein and that
        both the Vendors and their solicitors are satisfied with the results of
        such due diligence;   

	 	    	 
	 	•	 the Vendors and their accountant having had a reasonable
        opportunity to review the financial statements (including corporate tax
        returns, general ledger listings, adjusting entries and opening trial
        balances) of the Purchaser, prepared in accordance with generally accepted
        accounting principles and that both the Vendors and their accountant are
        satisfied with the content of such financial statements; and 

	 
	 	•	 no material adverse change having occurred in connection
        with the business of the Purchaser; and 

	 
	 	•	 approval of the Board of Directors of the Target
        and approval of all of the securityholders of the Target being obtained.
      

	 	 It would be the expectation of the Vendors that
        many of the Vendors’ Conditions Precedent will be narrowed or eliminated
        altogether as the Vendors complete their due diligence and the Formal
        Agreement and schedules thereto are finalized. 

	 
	 12.      	 Closing: The closing (the "Closing") of the
        transactions contemplated by this Letter of Intent will occur not later
        than 10 days following the satisfaction or written waiver by the Purchaser
        of the Conditions Precedent and the Vendor of the Vendors’ Conditions
        Precedent. At the Closing, the Vendors will transfer the Securities to
        the Purchaser free from any outstanding liens, charges, claims or encumbrances
        and execute all such documents as the Purchaser's solicitors may require
        in order to effect such transfer. The Closing may take place by exchange
        of the appropriate solicitor's undertakings, which will involve each party's
        solicitors delivering to his or her counterpart all required cash and
        documentation, to be held in trust and not released until all such cash
        and documentation has been executed and delivered to the Purchaser. 

	 
	 13.      	 Confidentiality: All negotiations regarding
        the Target and the Securities will be confidential and will not be disclosed
        to anyone other than respective advisors and internal staff of the parties
        and necessary third parties, such as lenders approached for financing.
        No press or other publicity release will be issued to the general public
        concerning the proposed transaction without mutual consent unless required
        by law, and then only upon prior written notice to the other party. 

	 
	 14.      	 Purchase and Sale Agreement: Upon execution
        of this Letter of Intent and payment of the Deposit, the Purchaser will
        prepare a draft of the Formal Agreement for the Vendors' review. 

	 
	 15.      	 Good Faith Negotiations: Each of the Purchaser
        and the Vendors will act honestly, diligently and in good faith in their
        respective endeavors to negotiate, settle and execute the Formal Agreement
        within 90 days following the execution of this Letter of Intent. 

 

	 16.      	 Exclusive Opportunity: For two (2) months
        following the execution of this Letter of Intent, neither the Target nor
        any of the Vendors will, directly or indirectly, solicit, initiate, entertain
        or accept any inquiries or proposals from, discuss or negotiate with,
        provide any non-public information to or consider the merits of any unsolicited
        inquiries or proposals from any person or entity to any transaction involving
        the sale of the business or assets of the Target or any of the securities
        of the Purchaser or any merger, consolidation, business combination or
        similar transaction involving the Target. The Target and the Vendors agree
        to promptly notify the Purchaser if any of them receives an unsolicited
        offer for such a transaction. 

	 
	 17.      	 Standstill Agreement: Following the execution
        of this Letter of Intent and until the Closing, the Vendors will not,
        directly or indirectly, purchase or sell any securities of the Purchaser.
      

	 
	 18.      	 Not a Binding Agreement: This Letter of Intent
        does not create a binding contract and will not be enforceable, except
        in respect of the obligations set out in paragraphs 9, 13, 15, 16 and
        17. Only the Formal Agreement, duly executed and delivered by all of the
        securityholders of the Target and Purchaser, will be enforceable, and
        it will supersede the provisions of this Letter of Intent and all other
        agreements and understandings between the Purchaser and the Vendors with
        respect to the subject matter of this Letter of Intent. 

	 
	 19.      	 Currency: All references to "$" in this
        Letter of Intent shall refer to currency of the United States of America.
      

	 
	 20.      	 Proper Law: This Letter of Intent will be
        governed by and construed in accordance with the law of the Province of
        British Columbia and the parties hereby attorn to the jurisdiction of
        the Courts of competent jurisdiction of the Province of British Columbia
        in any proceeding hereunder. 

	 
	 21.      	 Counterparts and Electronic Means: This Letter
        of Intent may be executed in several counterparts, each of which will
        be deemed to be an original and all of which will together constitute
        one and the same instrument. Delivery to us of an executed copy of this
        Letter of Intent by electronic facsimile transmission or other means of
        electronic communication capable of producing a printed copy will be deemed
        to be execution and delivery to us of this Letter of Intent as of the
        date of successful transmission to us. 

 

	 22.      	 Acceptance: If you are agreeable to the foregoing
        terms, please sign and return a duplicate copy of this Letter of Intent
        by no later than by 4:00 p.m. on September 17, 2004. Facsimile is acceptable.
      

  

	Yours truly, 

       GLOBAL INNOVATIVE SYSTEMS, INC. 
	 
	 	 	 
	 	 	 
	 	 
	Name: William McGinty 

      Title:    President 	 

The above terms are accepted this 21st day of September, 2004. 

	 SIGNED, SEALED and DELIVERED by  	 )  	 	  
	 VICTOR CHANG in the presence of:  	 )  	 	  
	  	 )  	 	  
	  	 )  	 	  
	 Signature  	 )  	 	  
	  	 )  	 	  
	 Print Name  	 )  	 	 VICTOR CHANG  
	  	 )  	 	  
	 Address  	 )  	 	  
	  	 )  	 	  
	  	 )  	 	  
	  	 )  	 	  
	 Occupation  	 )  	 	  

 

	 SIGNED, SEALED and DELIVERED by  	 )  	 	  
	 BONDY TAN in the presence of:  	 )  	 	  
	  	 )  	 	  
	  	 )  	 	  
	 Signature  	 )  	 	  
	  	 )  	 	  
	 Print Name  	 )  	 	 BONDY TAN  
	  	 )  	 	  
	 Address  	 )  	 	  
	  	 )  	 	  
	  	 )  	 	  
	  	 )  	 	  
	 Occupation  	 )  	 	  
	  	 	 	 
	  	 	 	 
	 SIGNED, SEALED and DELIVERED by  	 )  	 	  
	 DR. CHARLES CHEUNG in the presence  	 )  	 	  
	 of:  	 )  	 	  
	  	 )  	 	  
	  	 )  	 	  
	 Signature  	 )  	 	  
	  	 )  	 	 DR. CHARLES CHEUNG  
	 Print Name  	 )  	 	  
	  	 )  	 	  
	 Address  	 )  	 	  
	  	 )  	 	  
	  	 )  	 	  
	  	 )  	 	  
	 Occupation

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}]]